respimmun.at

Welcome

Description

Faculty

• Böhm
• Brčić
• Heinemann
• Höfler
• Kargl
• Kwapiszewska
• Leithner
Marsche ⏩
• Marsh
• Moissl-Eichinger
• Olschewski A
• Olschewski H
• Strobl
• Tomazic

Young Faculty

Students

Training

Publications

PhD Program
Congress (Retreat)

 

• Webmaster

The RESPImmun Faculty

Gunther MARSCHE, PhD

Lysophosphatidylcholines and eosinophil function

Otto Loewi Research Centre, Division of Pharmacology, Medical University of Graz, Neue Stiftingtalstraße 6, A-8010 Graz;
phone: +43-316-385 74128, fax: +43-316-385 79613,  e-mail
websites: [RESPImmun]
• Profile     • Curriculum vitae     • PhD students     • Grants     • Pubications ⏬    

List of publications:

10 most significant publications:

  1. Knuplez E, Kienzl M, Trakaki A, Schicho R, Heinemann A, Böhm EM, Marsche G: The anti-parasitic drug miltefosine suppresses activation of human eosinophils and ameliorates allergic inflammation in mice. Br J Pharmacoll, 2021; 178(5):​1234–1248.
  2. Trieb M, Rainer F, Stadlbauer V, Douschan P, Horvath A, Binder L, Trakaki A, Knuplez E, Scharnagl H, Stojakovic T, Heinemann Á, Mandorfer M, Paternostro R, Reiberger T, Pitarch C, Amorós A, Gerbes A, Caraceni P, Alessandria C, Moreau R, Clària J, Marsche G, Stauber RE: HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure. J Hepatol, 2020; 73(1):​113–120.
  3. Bauer L, Kern S, Rogacev KS, Emrich IE, Zawada A, Fliser D, Heinemann A, Heine GH, Marsche G: HDL Cholesterol Efflux Capacity and Cardiovascular Events in Patients With Chronic Kidney Disease. J Am Coll Cardiol, 2017; 69(2):​246–247.
  4. Jandl K, Stacher E, Bálint Z, Böhm EM, Maric J, Peinhaupt M, Luschnig P, Aringer I, Fauland A, Konya V, Dahlen SE, Wheelock CE, Kratky D, Olschewski A, Marsche G, Schuligoi R, Heinemann A: Activated prostaglandin D2 receptors on macrophages enhance neutrophil recruitment into the lung. J Allergy Clin Immunol, 2016; 137(3):​833–843.
  5. El-Gamal D, Rao SP, Holzer M, Hallström S, Haybaeck J, Gauster M, Wadsack C, Kozina A, Frank S, Schicho R, Schuligoi R, Heinemann A, Marsche G: The urea decomposition product cyanate promotes endothelial dysfunction. Kidney Int, 2014; 86(5):​923–931.
  6. Ljubojevic S, Radulovic S, Leitinger G, Sedej S, Sacherer M, Holzer M, Winkler C, Pritz E, Mittler T, Schmidt A, Sereinigg M, Wakula P, Zissimopoulos S, Bisping E, Post H, Marsche G, Bossuyt J, Bers DM, Kockskämper J, Pieske B: Early remodeling of perinuclear Ca2+ stores and nucleoplasmic Ca2+ signaling during the development of hypertrophy and heart failure. Circulation, 2014; 130(3):​244–255.
  7. Holzer M, Birner-Gruenberger R, Stojakovic T, El-Gamal D, Binder V, Wadsack C, Heinemann A, Marsche G: Uremia alters HDL composition and function. J Am Soc Nephrol, 2011; 22(9):​1631–1641.
  8. Holzer M, Gauster M, Pfeifer T, Wadsack C, Fauler G, Stiegler P, Koefeler H, Beubler E, Schuligoi R, Heinemann A, Marsche G: Protein carbamylation renders high-density lipoprotein dysfunctional. Antioxid Redox Signal, 2011; 14(12):​2337–2346.
  9. Marsche G, Frank S, Hrzenjak A, Holzer M, Dirnberger S, Wadsack C, Scharnagl H, Stojakovic T, Heinemann A, Oettl K: Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo. Circ Res, 2009; 104(6):​750–757.
  10. Schaefer L, Babelova A, Kiss E, Hausser HJ, Baliova M, Krzyzankova M, Marsche G, Young MF, Mihalik D, Götte M, Malle E, Schaefer RM, Gröne HJ: The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest, 2005; 115(8):​2223–2233.